US5795714A
(en)
*
|
1992-11-06 |
1998-08-18 |
Trustees Of Boston University |
Method for replicating an array of nucleic acid probes
|
US6436635B1
(en)
*
|
1992-11-06 |
2002-08-20 |
Boston University |
Solid phase sequencing of double-stranded nucleic acids
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US5605798A
(en)
*
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
US5547835A
(en)
|
1993-01-07 |
1996-08-20 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US6074823A
(en)
*
|
1993-03-19 |
2000-06-13 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
PT700521E
(en)
*
|
1993-05-28 |
2003-10-31 |
Baylor College Medicine |
METHOD AND MASS SPECTROMETER FOR DESSORING AND IONIZATION OF ANALYZES
|
US20020037517A1
(en)
*
|
1993-05-28 |
2002-03-28 |
Hutchens T. William |
Methods for sequencing biopolymers
|
US6428955B1
(en)
|
1995-03-17 |
2002-08-06 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
US20060063193A1
(en)
*
|
1995-04-11 |
2006-03-23 |
Dong-Jing Fu |
Solid phase sequencing of double-stranded nucleic acids
|
US7803529B1
(en)
|
1995-04-11 |
2010-09-28 |
Sequenom, Inc. |
Solid phase sequencing of biopolymers
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
US20030027216A1
(en)
*
|
2001-07-02 |
2003-02-06 |
Kiernan Urban A. |
Analysis of proteins from biological fluids using mass spectrometric immunoassay
|
US20020164818A1
(en)
*
|
1995-05-23 |
2002-11-07 |
Gruber Karl F. |
Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
|
WO1996037777A1
(en)
*
|
1995-05-23 |
1996-11-28 |
Nelson Randall W |
Mass spectrometric immunoassay
|
US6316266B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Arizona State University Board Of Regents |
Sample presentation apparatus for mass spectrometry
|
US6146854A
(en)
*
|
1995-08-31 |
2000-11-14 |
Sequenom, Inc. |
Filtration processes, kits and devices for isolating plasmids
|
JP3623025B2
(en)
*
|
1995-09-29 |
2005-02-23 |
日機装株式会社 |
Mixed gas component analyzer
|
DE19543065C2
(en)
*
|
1995-11-09 |
2002-10-31 |
Gag Bioscience Gmbh Zentrum Fu |
Genome analysis method and means for performing the method
|
US6613508B1
(en)
*
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
US6852487B1
(en)
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
EP0886681A1
(en)
*
|
1996-03-04 |
1998-12-30 |
Genetrace Systems, Inc. |
Methods of screening nucleic acids using mass spectrometry
|
US5945675A
(en)
*
|
1996-03-18 |
1999-08-31 |
Pacific Northwest Research Foundation |
Methods of screening for a tumor or tumor progression to the metastatic state
|
AU2462497A
(en)
|
1996-04-17 |
1997-11-19 |
Hubert Koster |
A combinatorial protecting group strategy for multifunctional molecules
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
EP0912761A4
(en)
|
1996-05-29 |
2004-06-09 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
|
DE19633436A1
(en)
*
|
1996-08-20 |
1998-02-26 |
Boehringer Mannheim Gmbh |
Method for the detection of nucleic acids by determining the mass
|
US5965363A
(en)
*
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5777324A
(en)
*
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
US5885775A
(en)
*
|
1996-10-04 |
1999-03-23 |
Perseptive Biosystems, Inc. |
Methods for determining sequences information in polynucleotides using mass spectrometry
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
DE19782095T1
(en)
*
|
1996-11-06 |
2000-03-23 |
Sequenom Inc |
DNA diagnosis based on mass spectrometry
|
DK0937096T3
(en)
|
1996-11-06 |
2004-06-14 |
Sequenom Inc |
Method of mass spectrometry analysis
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
US6024925A
(en)
|
1997-01-23 |
2000-02-15 |
Sequenom, Inc. |
Systems and methods for preparing low volume analyte array elements
|
US7285422B1
(en)
*
|
1997-01-23 |
2007-10-23 |
Sequenom, Inc. |
Systems and methods for preparing and analyzing low volume analyte array elements
|
DE69735445T2
(en)
*
|
1996-12-10 |
2006-08-10 |
Sequenom, Inc., San Diego |
NON-VOLATILE, NON-VOLATILE MOLECULES FOR MASS MARKING
|
EP1249705A3
(en)
*
|
1996-12-31 |
2003-11-05 |
Genometrix Genomics Incorporated |
Multiplexed molecular analysis apparatus and its fabrication method
|
US20050042625A1
(en)
*
|
1997-01-15 |
2005-02-24 |
Xzillion Gmbh & Co. |
Mass label linked hybridisation probes
|
WO1998040520A1
(en)
*
|
1997-03-14 |
1998-09-17 |
Hybridon, Inc. |
Method for sequencing of modified nucleic acids using electrospray ionization-fourier transform mass spectrometry
|
CA2292039A1
(en)
*
|
1997-05-28 |
1998-12-03 |
The Walter And Eliza Hall Institute Of Medical Research |
Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage
|
AU743146B2
(en)
*
|
1997-05-28 |
2002-01-17 |
Walter And Eliza Hall Institute Of Medical Research, The |
Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
CN1265156A
(en)
*
|
1997-07-22 |
2000-08-30 |
拉普吉恩公司 |
Amplification and other enzymatic reactions preformed on nucleic acid arrays
|
US6207370B1
(en)
|
1997-09-02 |
2001-03-27 |
Sequenom, Inc. |
Diagnostics based on mass spectrometric detection of translated target polypeptides
|
US20110166040A1
(en)
*
|
1997-09-05 |
2011-07-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of e. coli o157:h7
|
AU9400398A
(en)
*
|
1997-09-19 |
1999-04-05 |
Genetrace Systems, Inc. |
Dna typing by mass spectrometry with polymorphic dna repeat markers
|
US6764822B1
(en)
|
1997-09-19 |
2004-07-20 |
Sequenom, Inc. |
DNA typing by mass spectrometry with polymorphic DNA repeat markers
|
US8236500B2
(en)
*
|
1997-10-23 |
2012-08-07 |
The United States Of America, As Represented By The Department Of Veterans Affairs |
Promoter variants of the alpha-7 nicotinic acetylcholine receptor
|
AU741141B2
(en)
|
1997-11-04 |
2001-11-22 |
Roche Diagnostics Gmbh |
Specific and sensitive method for detecting nucleic acids
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US6232066B1
(en)
*
|
1997-12-19 |
2001-05-15 |
Neogen, Inc. |
High throughput assay system
|
WO2000037684A1
(en)
*
|
1998-12-22 |
2000-06-29 |
Kris Richard M |
High throughput assay system using mass spectrometry
|
US6238869B1
(en)
|
1997-12-19 |
2001-05-29 |
High Throughput Genomics, Inc. |
High throughput assay system
|
US20100105572A1
(en)
*
|
1997-12-19 |
2010-04-29 |
Kris Richard M |
High throughput assay system
|
US6458533B1
(en)
|
1997-12-19 |
2002-10-01 |
High Throughput Genomics, Inc. |
High throughput assay system for monitoring ESTs
|
US20030039967A1
(en)
*
|
1997-12-19 |
2003-02-27 |
Kris Richard M. |
High throughput assay system using mass spectrometry
|
US20030096232A1
(en)
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
US6407816B1
(en)
*
|
1998-02-23 |
2002-06-18 |
Zygo Corporation |
Interferometer and method for measuring the refractive index and optical path length effects of air
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
US6428956B1
(en)
*
|
1998-03-02 |
2002-08-06 |
Isis Pharmaceuticals, Inc. |
Mass spectrometric methods for biomolecular screening
|
WO1999053102A1
(en)
*
|
1998-04-16 |
1999-10-21 |
Packard Bioscience Company |
Analysis of polynucleotide sequence
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6723564B2
(en)
|
1998-05-07 |
2004-04-20 |
Sequenom, Inc. |
IR MALDI mass spectrometry of nucleic acids using liquid matrices
|
AU3943799A
(en)
*
|
1998-05-15 |
1999-12-06 |
Isis Innovation Limited |
Reagent and method
|
US6104028A
(en)
|
1998-05-29 |
2000-08-15 |
Genetrace Systems Inc. |
Volatile matrices for matrix-assisted laser desorption/ionization mass spectrometry
|
US6218118B1
(en)
|
1998-07-09 |
2001-04-17 |
Agilent Technologies, Inc. |
Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry
|
US5965358A
(en)
*
|
1998-08-26 |
1999-10-12 |
Genvec, Inc. |
Method for assessing the relative purity of viral gene transfer vector stocks
|
US6500650B1
(en)
|
1998-10-01 |
2002-12-31 |
Variagenics, Inc. |
Method for identifying polymorphisms
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6855500B2
(en)
|
1998-10-01 |
2005-02-15 |
Sequenom, Inc. |
Fluorescence-based genotyping
|
US6610492B1
(en)
|
1998-10-01 |
2003-08-26 |
Variagenics, Inc. |
Base-modified nucleotides and cleavage of polynucleotides incorporating them
|
US6994998B1
(en)
|
1998-10-01 |
2006-02-07 |
Sequenom, Inc. |
Base-modified nucleotides and their use for polymorphism detection
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6777188B2
(en)
|
1998-10-01 |
2004-08-17 |
Variagenics, Inc. |
Genotyping by mass spectrometric analysis of allelic fragments
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
CA2346487A1
(en)
*
|
1998-10-14 |
2000-04-20 |
Matthew R. Bonen |
Immobilized silver immunoassay system
|
GB9824444D0
(en)
*
|
1998-11-06 |
1999-01-06 |
Univ Manchester Metropolitan |
Micro-Organism identification
|
AUPP702498A0
(en)
*
|
1998-11-09 |
1998-12-03 |
Silverbrook Research Pty Ltd |
Image creation method and apparatus (ART77)
|
DE19905082C1
(en)
*
|
1999-01-29 |
2000-05-18 |
Epigenomics Gmbh |
Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine
|
US6225061B1
(en)
|
1999-03-10 |
2001-05-01 |
Sequenom, Inc. |
Systems and methods for performing reactions in an unsealed environment
|
US6436640B1
(en)
*
|
1999-03-18 |
2002-08-20 |
Exiqon A/S |
Use of LNA in mass spectrometry
|
US20020009394A1
(en)
|
1999-04-02 |
2002-01-24 |
Hubert Koster |
Automated process line
|
US6994969B1
(en)
|
1999-04-30 |
2006-02-07 |
Methexis Genomics, N.V. |
Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
|
EP1072679A3
(en)
*
|
1999-07-20 |
2002-07-31 |
Agilent Technologies, Inc. (a Delaware corporation) |
Method of producing nucleic acid molecules with reduced secondary structure
|
DE19938138C2
(en)
*
|
1999-08-16 |
2003-02-13 |
November Ag Molekulare Medizin |
Method and device for identifying a biopolymer sequence on solid surfaces
|
US6306628B1
(en)
*
|
1999-08-25 |
2001-10-23 |
Ambergen, Incorporated |
Methods for the detection, analysis and isolation of Nascent proteins
|
US6869572B1
(en)
|
1999-09-13 |
2005-03-22 |
Millipore Corporation |
High density cast-in-place sample preparation card
|
EP1227888A4
(en)
*
|
1999-09-13 |
2006-05-24 |
Millipore Corp |
High density cast-in-place sample preparation card
|
CA2386791A1
(en)
|
1999-10-08 |
2001-04-19 |
Protogene Laboratories, Inc. |
Method and apparatus for performing large numbers of reactions using array assembly
|
US7332275B2
(en)
*
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
KR20020064298A
(en)
|
1999-10-13 |
2002-08-07 |
시쿼넘, 인코포레이티드 |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7917301B1
(en)
|
2000-09-19 |
2011-03-29 |
Sequenom, Inc. |
Method and device for identifying a biological sample
|
US20030207297A1
(en)
*
|
1999-10-13 |
2003-11-06 |
Hubert Koster |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US6709816B1
(en)
*
|
1999-10-18 |
2004-03-23 |
Affymetrix, Inc. |
Identification of alleles
|
CN1238721C
(en)
*
|
1999-12-20 |
2006-01-25 |
宾夕法尼亚州研究基金会 |
Deposited thin films and their use in detection, attachment and bio-medical application
|
CA2400379A1
(en)
*
|
2000-02-16 |
2001-08-23 |
Quantum Dot Corporation |
Microarray methods utilizing semiconductor nanocrystals
|
CN1444646A
(en)
*
|
2000-02-23 |
2003-09-24 |
齐翁米克斯股份有限公司 |
Chips having elevated sample surfaces
|
DE10010280B4
(en)
*
|
2000-02-25 |
2006-08-10 |
Epigenomics Ag |
Method for the detection of cytosine methylation in DNA samples
|
DE10010282B4
(en)
*
|
2000-02-25 |
2006-11-16 |
Epigenomics Ag |
Method for the detection of cytosine methylation in DNA samples
|
AU2001248352A1
(en)
*
|
2000-03-15 |
2001-09-24 |
Epigenomics Ag |
Diagnosis of diseases associated with the cell cycle
|
DE10032529A1
(en)
*
|
2000-06-30 |
2002-02-07 |
Epigenomics Ag |
Diagnosis of major genetic parameters within the Major Histocompatibility Complex (MHC)
|
AU2001253462A1
(en)
*
|
2000-04-13 |
2001-11-12 |
Thermo Finnigan, Llc |
Proteomic analysis by parallel mass spectrometry
|
DE10021204A1
(en)
*
|
2000-04-25 |
2001-11-08 |
Epigenomics Ag |
Method for the highly parallel analysis of polymorphisms
|
KR20010097731A
(en)
*
|
2000-04-25 |
2001-11-08 |
김희태 |
Multiplexed PCR in one tube with numerous different type of primers that bound on tube bottom surface at specific site to each other primers( one strand of sense or antisense ) and detected by hybridization with labelled Probe.
|
DE10027120A1
(en)
*
|
2000-05-23 |
2001-12-06 |
Epigenomics Ag |
Sample holder for mass spectrometer
|
US6660229B2
(en)
|
2000-06-13 |
2003-12-09 |
The Trustees Of Boston University |
Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
|
EP1170379A1
(en)
*
|
2000-06-30 |
2002-01-09 |
Centre National de Genotypage |
Sample generation for genotyping by mass spectrometry
|
AU2001278872A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Genvec, Inc. |
Method of identifying a binding partner of a gene product
|
DE10033091A1
(en)
*
|
2000-07-07 |
2002-01-31 |
Max Planck Gesellschaft |
Polymer chip
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
EP1366185B9
(en)
*
|
2000-07-11 |
2007-10-17 |
Kirk Hogan |
Methods and compositions for perioperative genomic profiling
|
DE10036743A1
(en)
*
|
2000-07-27 |
2002-02-07 |
Max Planck Gesellschaft |
Method for determining a partial nucleotide sequence of a nucleic acid molecule
|
AU2001283056A1
(en)
*
|
2000-07-27 |
2002-02-13 |
California Institute Of Technology |
A rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping
|
GB0021286D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Gemini Genomics Ab |
Identification of drug metabolic capacity
|
US20040185464A1
(en)
*
|
2000-09-15 |
2004-09-23 |
Kris Richard M. |
High throughput assay system
|
US6479242B1
(en)
|
2000-10-26 |
2002-11-12 |
Cleveland State University |
Method for genotyping of single nucleotide polymorphism
|
EP1332000B1
(en)
|
2000-10-30 |
2012-06-20 |
Sequenom, Inc. |
Method for delivery of submicroliter volumes onto a substrate
|
US7060442B2
(en)
*
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
US20030093819A1
(en)
|
2000-11-03 |
2003-05-15 |
D'andrea Alan D. |
Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
|
US20030188326A1
(en)
|
2000-11-03 |
2003-10-02 |
Dana Farber Cancer Institute |
Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
|
EP1350851A4
(en)
*
|
2000-12-12 |
2007-07-11 |
Chugai Pharmaceutical Co Ltd |
Method of detecting polymorphism in dna by using mass spectroscopy
|
US20030232332A1
(en)
*
|
2000-12-18 |
2003-12-18 |
Muralidhara Padigaru |
Novel proteins and nucleic acids encoding same
|
FI115139B
(en)
*
|
2001-01-10 |
2005-03-15 |
Valtion Teknillinen |
Method and test package for quantitative and / or comparative assessment of the variations of polynucleotide amounts in cell or tissue samples
|
JP2002214196A
(en)
*
|
2001-01-18 |
2002-07-31 |
Hitachi Ltd |
Dna analytic system
|
DE10108453B4
(en)
|
2001-02-22 |
2005-10-20 |
Bruker Daltonik Gmbh |
Mass spectrometric mutation analysis with photolytically cleavable primers
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
US20030027135A1
(en)
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
AU2003297687B2
(en)
*
|
2001-03-02 |
2009-11-26 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US7226739B2
(en)
*
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
AU2003298030B2
(en)
*
|
2001-03-02 |
2009-12-10 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
WO2002071066A1
(en)
*
|
2001-03-02 |
2002-09-12 |
Activx Biosciences, Inc. |
Protein profiling platform
|
US20040121335A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
|
US7718354B2
(en)
*
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20030036057A1
(en)
*
|
2001-03-09 |
2003-02-20 |
Andreas Braun |
Genes and polymorphisms associated with cardiovascular disease and their use
|
US6428964B1
(en)
|
2001-03-15 |
2002-08-06 |
Exact Sciences Corporation |
Method for alteration detection
|
IL158000A0
(en)
*
|
2001-03-19 |
2004-03-28 |
Harvard College |
Evolving new molecular function
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
KR100436554B1
(en)
*
|
2001-04-17 |
2004-06-18 |
삼성전자주식회사 |
A Method for Improving a Sensitivity of Sensing Device in the Detection of a Hybridized Nucleic Acid
|
US20020155587A1
(en)
|
2001-04-20 |
2002-10-24 |
Sequenom, Inc. |
System and method for testing a biological sample
|
AU2002305710A1
(en)
*
|
2001-05-25 |
2002-12-09 |
Waters Investments Limited |
Sample concentration maldi plates for maldi mass spectrometry
|
US7053366B2
(en)
|
2001-05-25 |
2006-05-30 |
Waters Investments Limited |
Desalting plate for MALDI mass spectrometry
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
EP2053406A3
(en)
*
|
2001-07-16 |
2009-06-24 |
caprotec bioanalytics GmbH |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US6686745B2
(en)
|
2001-07-20 |
2004-02-03 |
Shell Oil Company |
Apparatus and method for electrical testing of electrically heated pipe-in-pipe pipeline
|
US6714018B2
(en)
|
2001-07-20 |
2004-03-30 |
Shell Oil Company |
Method of commissioning and operating an electrically heated pipe-in-pipe subsea pipeline
|
US6814146B2
(en)
*
|
2001-07-20 |
2004-11-09 |
Shell Oil Company |
Annulus for electrically heated pipe-in-pipe subsea pipeline
|
US6739803B2
(en)
|
2001-07-20 |
2004-05-25 |
Shell Oil Company |
Method of installation of electrically heated pipe-in-pipe subsea pipeline
|
GB0120131D0
(en)
|
2001-08-17 |
2001-10-10 |
Micromass Ltd |
Maldi target plate
|
WO2004072616A2
(en)
*
|
2003-02-10 |
2004-08-26 |
Waters Investments Limited |
A sample preparation plate for mass spectrometry
|
US20030040129A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Shah Haresh P. |
Binding assays using magnetically immobilized arrays
|
US20050147984A1
(en)
*
|
2001-08-31 |
2005-07-07 |
Clondiag Chip Technologies Gmbh |
Interaction detection on several probe arrays
|
DE10144250A1
(en)
*
|
2001-08-31 |
2003-04-03 |
Fraunhofer Ges Forschung |
Improved mass spectrometric analysis using nanoparticles
|
US7108975B2
(en)
*
|
2001-09-21 |
2006-09-19 |
Regents Of The University Of Michigan |
Atlastin
|
US7582425B2
(en)
*
|
2001-09-21 |
2009-09-01 |
The Regents Of The University Of Michigan |
Atlastin
|
US20040019005A1
(en)
*
|
2001-10-01 |
2004-01-29 |
Jeffrey Van Ness |
Methods for parallel measurement of genetic variations
|
KR100442822B1
(en)
*
|
2001-10-23 |
2004-08-02 |
삼성전자주식회사 |
Methods for detecting binding of biomolecules using shear stress measurements
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
WO2003054143A2
(en)
*
|
2001-10-25 |
2003-07-03 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
CA2464682A1
(en)
*
|
2001-10-26 |
2003-05-01 |
Sequenom, Inc. |
Method and apparatus for high-throughput sample handling process line
|
US7045319B2
(en)
*
|
2001-10-30 |
2006-05-16 |
Ribomed Biotechnologies, Inc. |
Molecular detection systems utilizing reiterative oligonucleotide synthesis
|
EP1470246A2
(en)
*
|
2001-10-31 |
2004-10-27 |
Novartis AG |
Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
|
WO2003051174A2
(en)
*
|
2001-11-09 |
2003-06-26 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
AU2002358110A1
(en)
*
|
2001-12-10 |
2003-07-09 |
Novartis Ag |
Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
|
US20030148284A1
(en)
*
|
2001-12-17 |
2003-08-07 |
Vision Todd J. |
Solid phase detection of nucleic acid molecules
|
US20050106587A1
(en)
*
|
2001-12-21 |
2005-05-19 |
Micronas Gmbh |
Method for determining of nucleic acid analytes
|
US7195873B2
(en)
*
|
2001-12-27 |
2007-03-27 |
Myriad Genetics, Inc. |
Drug response marker in beta-1 adrenergic receptor gene
|
AU2003201159A1
(en)
|
2002-01-08 |
2003-07-24 |
Bayer Healthcare Ag |
Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
|
US7877273B2
(en)
*
|
2002-01-08 |
2011-01-25 |
Fredric David Abramson |
System and method for evaluating and providing nutrigenomic data, information and advice
|
US7255986B2
(en)
*
|
2002-01-31 |
2007-08-14 |
The Board Of Trustees Operating Michigan State University |
Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
|
US20030148288A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Yi-Wei Tang |
Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
|
EP1333101B1
(en)
|
2002-02-01 |
2007-03-28 |
Bruker Daltonik GmbH |
Mutation analysis by PCR and Mass spectrometry
|
AU2003215083A1
(en)
*
|
2002-02-06 |
2003-09-02 |
Tethys Bioscience, Inc. |
Method and apparatus for validating dna sequences without sequencing
|
WO2004038040A2
(en)
*
|
2002-02-21 |
2004-05-06 |
Sense Proteomic Limited |
Enzyme array and assay
|
US6977162B2
(en)
|
2002-03-01 |
2005-12-20 |
Ravgen, Inc. |
Rapid analysis of variations in a genome
|
BR0200690A
(en)
*
|
2002-03-04 |
2004-03-23 |
Embrapa Pesquisa Agropecuaria |
Method for detection of source proteins in complex mixtures
|
JP3530942B2
(en)
*
|
2002-03-05 |
2004-05-24 |
独立行政法人通信総合研究所 |
Molecular beam generation method and apparatus
|
US20040209255A1
(en)
*
|
2002-03-11 |
2004-10-21 |
Hk Pharmaceuticals, Inc. |
Compounds and methods for analyzing the proteome
|
US6723546B2
(en)
*
|
2002-03-26 |
2004-04-20 |
New England Biolabs, Inc. |
Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
|
WO2003083130A2
(en)
|
2002-03-28 |
2003-10-09 |
The Johns Hopkins University |
Detection of malaria parasites by mass spectrometry
|
WO2003100035A2
(en)
*
|
2002-04-01 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Method for rapid detection and identification of viral bioagents
|
US7432342B2
(en)
*
|
2002-05-03 |
2008-10-07 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof and related documents
|
US7442506B2
(en)
*
|
2002-05-08 |
2008-10-28 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
US20030220844A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Marnellos Georgios E. |
Method and system for purchasing genetic data
|
US20030219755A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Nanibhushan Dattagupta |
Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA)
|
WO2003102216A2
(en)
|
2002-05-31 |
2003-12-11 |
Diversa Corporation |
Multiplexed systems for nucleic acid sequencing
|
WO2003101177A2
(en)
*
|
2002-06-04 |
2003-12-11 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
|
SE0201705D0
(en)
*
|
2002-06-05 |
2002-06-05 |
Sp Sveriges Provnings Och Fors |
Improved analysis
|
US6688900B2
(en)
|
2002-06-25 |
2004-02-10 |
Shell Oil Company |
Insulating joint for electrically heated pipeline
|
EP1581095A4
(en)
*
|
2002-06-27 |
2006-10-18 |
Harkness Pharmaceuticals Inc |
Therapeutic methods for reducing fat deposition and treating associated conditions
|
US20050239077A1
(en)
*
|
2002-06-27 |
2005-10-27 |
Adam Gail I R |
Diagnosing predisposition to fat deposition and associated conditions
|
FI20021325A0
(en)
*
|
2002-07-05 |
2002-07-05 |
Valtion Teknillinen |
Method and kit for determining the amount of individual polynucleotides
|
US20040009574A1
(en)
*
|
2002-07-09 |
2004-01-15 |
Nanibhushan Dattagupta |
Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes
|
US20040009482A1
(en)
*
|
2002-07-09 |
2004-01-15 |
Nanibhushan Dattagupta |
Compositions and methods for detecting streptococcus agalactiae surface immunogenic protein genes
|
US6624409B1
(en)
|
2002-07-30 |
2003-09-23 |
Agilent Technologies, Inc. |
Matrix assisted laser desorption substrates for biological and reactive samples
|
WO2004011625A2
(en)
|
2002-07-31 |
2004-02-05 |
University Of Southern California |
Polymorphisms for predicting disease and treatment outcome
|
US20060073475A1
(en)
*
|
2002-08-09 |
2006-04-06 |
Nanibhushan Dattagupta |
Compositions and methods for detecting pathogenic bacteria expressing chaperonin proteins
|
WO2004016767A2
(en)
*
|
2002-08-19 |
2004-02-26 |
The President And Fellows Of Harvard College |
Evolving new molecular function
|
DE10240746A1
(en)
*
|
2002-09-01 |
2004-03-18 |
Epigenomics Ag |
Method for the detection of nucleic acid sequences using cleavable probe molecules
|
AU2003272361A1
(en)
*
|
2002-09-11 |
2005-04-11 |
Sequenom, Inc. |
Methods for identifying subjects at risk of melanoma and treatments thereof
|
US20040050787A1
(en)
*
|
2002-09-13 |
2004-03-18 |
Elena Chernokalskaya |
Apparatus and method for sample preparation and direct spotting eluants onto a MALDI-TOF target
|
EP1576185A4
(en)
*
|
2002-10-18 |
2008-04-16 |
Genematrix Inc |
Method for detecting mutations
|
US6863731B2
(en)
*
|
2002-10-18 |
2005-03-08 |
Controls Corporation Of America |
System for deposition of inert barrier coating to increase corrosion resistance
|
WO2004044163A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Sequenom, Inc. |
Methods for identifying risk of melanoma and treatments thereof
|
US6937030B2
(en)
*
|
2002-11-08 |
2005-08-30 |
Shell Oil Company |
Testing electrical integrity of electrically heated subsea pipelines
|
WO2004046327A2
(en)
*
|
2002-11-14 |
2004-06-03 |
Genta Salus Llc |
Inhibitory oliogonucleotides targeted to bcl-2
|
US20050064442A1
(en)
*
|
2002-11-25 |
2005-03-24 |
Roth Richard B. |
Methods for identifying risk of breast cancer and treatments thereof
|
WO2004048548A2
(en)
*
|
2002-11-25 |
2004-06-10 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
EP2112229A3
(en)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
ATE426043T1
(en)
*
|
2002-11-25 |
2009-04-15 |
Sequenom Inc |
METHOD FOR IDENTIFYING BREAST CANCER RISK
|
CA2507189C
(en)
*
|
2002-11-27 |
2018-06-12 |
Sequenom, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
CA2508726A1
(en)
|
2002-12-06 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20040122857A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in forensic studies thereby
|
US20040121312A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of the absence of bioagents
|
US20040121315A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in containers thereby
|
CA2512110A1
(en)
|
2002-12-31 |
2004-07-22 |
Mmi Genomics, Inc. |
Compositions, methods, and systems for inferring bovine breed
|
CA2658334C
(en)
*
|
2003-01-16 |
2012-07-10 |
Caprotec Bioanalytics Gmbh |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US20070141570A1
(en)
*
|
2003-03-07 |
2007-06-21 |
Sequenom, Inc. |
Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
|
WO2004081191A2
(en)
*
|
2003-03-12 |
2004-09-23 |
Cleveland State University |
Molecular haplotyping of genomic dna
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
JP2006527190A
(en)
|
2003-04-17 |
2006-11-30 |
サイファージェン バイオシステムズ インコーポレイテッド |
Polypeptides related to natriuretic peptides and their identification and use
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
AU2004235331B2
(en)
*
|
2003-04-25 |
2008-12-18 |
Sequenom, Inc. |
Fragmentation-based methods and systems for De Novo sequencing
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US20040219532A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Sampson Jeffrey R. |
Internal references measurements
|
US20070037140A1
(en)
*
|
2003-05-09 |
2007-02-15 |
Capital Biochip Company, Ltd. |
Methods and compositions for detecting sars virus
|
US7964343B2
(en)
*
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
*
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US20040248104A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Zohar Yakhini |
Methods and reagents for profiling quantities of nucleic acids
|
CN100494399C
(en)
*
|
2003-06-30 |
2009-06-03 |
清华大学 |
Genotype typing method based on DNA chip and use thereof
|
EP1493824A1
(en)
*
|
2003-07-02 |
2005-01-05 |
Consortium National de Recherche en Genomique (CNRG) |
Method for detection of mutations in DNA
|
US20050233341A1
(en)
*
|
2003-07-23 |
2005-10-20 |
Roth Richard R |
Methods for identifying risk of melanoma and treatments thereof
|
US20050272043A1
(en)
*
|
2003-07-24 |
2005-12-08 |
Roth Richard B |
Methods for identifying risk of breast cancer and treatments thereof
|
US8003317B2
(en)
|
2003-07-31 |
2011-08-23 |
Sequenom, Inc. |
Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions
|
US7871768B2
(en)
|
2003-08-04 |
2011-01-18 |
The Hospital For Sick Children |
Lafora's disease gene
|
CN1580283A
(en)
*
|
2003-08-13 |
2005-02-16 |
清华大学 |
Method for detecting nucleic acid molecule
|
KR100647277B1
(en)
*
|
2003-08-14 |
2006-11-17 |
삼성전자주식회사 |
PCR primer set for a detection of hepatitis B and a hepatitis B detection kit comprising the same
|
US20050123952A1
(en)
*
|
2003-09-04 |
2005-06-09 |
Griffey Richard H. |
Methods of rapid detection and identification of bioagents using microRNA
|
WO2005024068A2
(en)
*
|
2003-09-05 |
2005-03-17 |
Sequenom, Inc. |
Allele-specific sequence variation analysis
|
US6977143B1
(en)
*
|
2003-09-08 |
2005-12-20 |
Quest Diagnostics Investments Incorporated |
Determination of testosterone by mass spectrometry
|
US20100129811A1
(en)
*
|
2003-09-11 |
2010-05-27 |
Ibis Biosciences, Inc. |
Compositions for use in identification of pseudomonas aeruginosa
|
US20120122099A1
(en)
|
2003-09-11 |
2012-05-17 |
Rangarajan Sampath |
Compositions for use in identification of bacteria
|
US20060240412A1
(en)
*
|
2003-09-11 |
2006-10-26 |
Hall Thomas A |
Compositions for use in identification of adenoviruses
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US20100035239A1
(en)
*
|
2003-09-11 |
2010-02-11 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of bacteria
|
US20080138808A1
(en)
*
|
2003-09-11 |
2008-06-12 |
Hall Thomas A |
Methods for identification of sepsis-causing bacteria
|
US7964344B2
(en)
*
|
2003-09-17 |
2011-06-21 |
Canon Kabushiki Kaisha |
Stable hybrid
|
ES2453895T3
(en)
|
2003-09-23 |
2014-04-08 |
University Of North Carolina At Chapel Hill |
Cells expressing vitamin K epoxide reductase and use thereof
|
US20050142584A1
(en)
*
|
2003-10-01 |
2005-06-30 |
Willson Richard C. |
Microbial identification based on the overall composition of characteristic oligonucleotides
|
WO2005042709A2
(en)
*
|
2003-10-29 |
2005-05-12 |
Ribomed Biotechnologies, Inc. |
Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
US7276338B2
(en)
*
|
2003-11-17 |
2007-10-02 |
Jacobson Joseph M |
Nucleotide sequencing via repetitive single molecule hybridization
|
EP1536021A1
(en)
|
2003-11-27 |
2005-06-01 |
Consortium National de Recherche en Genomique (CNRG) |
Method for HLA typing
|
US8163895B2
(en)
|
2003-12-05 |
2012-04-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of orthopoxviruses
|
JP2007517511A
(en)
*
|
2004-01-10 |
2007-07-05 |
バイエル・ヘルスケア・エルエルシー |
Haplotypes and polymorphisms associated with human thiopurine S-methyltransferase deficiency
|
US7432057B2
(en)
*
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
US20050191678A1
(en)
*
|
2004-02-12 |
2005-09-01 |
Geneob Usa Inc. |
Genetic predictability for acquiring a disease or condition
|
US7666592B2
(en)
*
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
WO2005080605A2
(en)
|
2004-02-19 |
2005-09-01 |
Helicos Biosciences Corporation |
Methods and kits for analyzing polynucleotide sequences
|
US20050186579A1
(en)
*
|
2004-02-23 |
2005-08-25 |
Dellinger Douglas J. |
MALDI-MS analysis of nucleic acids bound to a surface
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
US7312036B2
(en)
*
|
2004-03-22 |
2007-12-25 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of viral hemorrhagic fever viruses
|
US7608394B2
(en)
|
2004-03-26 |
2009-10-27 |
Sequenom, Inc. |
Methods and compositions for phenotype identification based on nucleic acid methylation
|
CA2561381C
(en)
*
|
2004-03-26 |
2015-05-12 |
Sequenom, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
US7459548B2
(en)
*
|
2004-05-21 |
2008-12-02 |
Mo Bio Laboratories, Inc. |
Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
|
CA2567839C
(en)
|
2004-05-24 |
2011-06-28 |
Isis Pharmaceuticals, Inc. |
Mass spectrometry with selective ion filtration by digital thresholding
|
US20050266411A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
WO2005118856A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US7785843B2
(en)
*
|
2004-06-23 |
2010-08-31 |
Sequenom, Inc. |
Target-specific compomers and methods of use
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
EP1773860A4
(en)
*
|
2004-07-22 |
2009-05-06 |
Sequenom Inc |
Methods for identifying risk of type ii diabetes and treatments thereof
|
WO2006031745A2
(en)
*
|
2004-09-10 |
2006-03-23 |
Sequenom, Inc. |
Methods for long-range sequence analysis of nucleic acids
|
ATE469245T1
(en)
|
2004-09-14 |
2010-06-15 |
Univ Colorado |
GENETIC TARGETING-BASED METHOD FOR TREATMENT WITH BUCINDOLOL
|
EP1804609A2
(en)
*
|
2004-09-29 |
2007-07-11 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. |
Monitoring of convection enhanced drug delivery
|
US7445896B2
(en)
*
|
2004-10-18 |
2008-11-04 |
University Of Washington |
Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
|
GB0423873D0
(en)
*
|
2004-10-27 |
2004-12-01 |
Univ Erasmus |
Nucleic acid analysis
|
US8084207B2
(en)
*
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
CA2600184A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of adventitious viruses
|
AU2005329450A1
(en)
|
2005-03-15 |
2006-09-28 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active Vitamin K-dependent proteins
|
US7972867B2
(en)
|
2005-04-06 |
2011-07-05 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin D metabolites by mass spectrometry
|
US7745226B2
(en)
|
2005-04-06 |
2010-06-29 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin D metabolites
|
EP1891244B1
(en)
*
|
2005-04-13 |
2010-10-06 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adenoviruses
|
US8486629B2
(en)
*
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
US8003395B2
(en)
*
|
2005-06-21 |
2011-08-23 |
Trace Bio Analytics, Llc |
Non-signal imidazole reagents for mass spectrometry analysis of phosphomonoesters
|
US20110045991A1
(en)
*
|
2005-06-23 |
2011-02-24 |
Sadanand Gite |
Methods for the Detection of Colorectal Cancer
|
US8026084B2
(en)
*
|
2005-07-21 |
2011-09-27 |
Ibis Biosciences, Inc. |
Methods for rapid identification and quantitation of nucleic acid variants
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
US20070059739A1
(en)
*
|
2005-09-12 |
2007-03-15 |
Applera Corporation |
Pure miRNA Sample Preparation Method
|
EP1937838B1
(en)
|
2005-09-22 |
2011-03-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of using il-21
|
US7919279B2
(en)
*
|
2005-09-29 |
2011-04-05 |
Children's Hospital & Research Center At Oakland |
Methods and compositions for KIR genotyping
|
EP1957521B1
(en)
*
|
2005-10-17 |
2014-02-19 |
Ibis Biosciences, Inc. |
Compositions for use in identification of influenza viruses
|
AU2006337105B2
(en)
|
2005-11-01 |
2013-05-02 |
Abbvie Biotechnology Ltd |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
WO2007059348A2
(en)
*
|
2005-11-17 |
2007-05-24 |
Third Wave Technologies, Inc. |
Compositions and methods for detecting an hcv-1 subtype
|
WO2007076420A2
(en)
*
|
2005-12-20 |
2007-07-05 |
Ming-Sheng Lee |
Apparatus, methods and products for detecting genetic mutation
|
GB0601302D0
(en)
|
2006-01-23 |
2006-03-01 |
Semikhodskii Andrei |
Diagnostic methods and apparatus
|
WO2007112289A2
(en)
*
|
2006-03-23 |
2007-10-04 |
The Regents Of The University Of California |
Method for identification and sequencing of proteins
|
EP2010679A2
(en)
|
2006-04-06 |
2009-01-07 |
Ibis Biosciences, Inc. |
Compositions for the use in identification of fungi
|
US8933209B2
(en)
|
2006-04-26 |
2015-01-13 |
Abbvie Inc. |
Dep2 and its uses in major depressive disorder and other related disorders
|
US20070256148A1
(en)
*
|
2006-04-26 |
2007-11-01 |
Katz David A |
DEP2 and its uses in major depressive disorder and other related disorders
|
US8084734B2
(en)
*
|
2006-05-26 |
2011-12-27 |
The George Washington University |
Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
|
US20100285973A1
(en)
*
|
2006-05-30 |
2010-11-11 |
Synergenz Bioscience Limited of Sea Meadow House |
Methods and compositions for assessment of pulmonary function and disorders
|
EP2029777B1
(en)
|
2006-05-31 |
2017-03-08 |
Sequenom, Inc. |
Methods and compositions for the extraction of nucleic acid from a sample
|
EP2035439A4
(en)
|
2006-06-05 |
2010-01-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
AU2007260750A1
(en)
*
|
2006-06-16 |
2007-12-21 |
Sequenom, Inc. |
Methods and compositions for the amplification, detection and quantification of nucleic acid from a sample
|
US7972794B2
(en)
*
|
2006-07-18 |
2011-07-05 |
Quest Diagnostics Investments Incorporated |
Oxidized apoA-I determination by mass spectrometry
|
CA2657307A1
(en)
|
2006-07-21 |
2008-01-24 |
Amgen Inc. |
Method of detecting and/or measuring hepcidin in a sample
|
CN101611318B
(en)
|
2006-09-07 |
2015-03-04 |
奥塔哥创新有限公司 |
Biomarkers
|
JP5420412B2
(en)
*
|
2006-09-14 |
2014-02-19 |
アイビス バイオサイエンシズ インコーポレイティッド |
Targeted whole genome amplification method for pathogen identification
|
US8053247B2
(en)
*
|
2006-10-11 |
2011-11-08 |
Phynexus, Inc. |
Method and device for preparing an analyte for analysis by mass spectrometry
|
US8017015B2
(en)
|
2006-10-20 |
2011-09-13 |
Quest Diagnostics Investments Incorporated |
Monolithic column chromatography
|
US7604998B2
(en)
*
|
2006-10-26 |
2009-10-20 |
Integrated Dna Technologies, Inc |
Fingerprint analysis for a plurality of oligonucleotides
|
EP2076172A4
(en)
*
|
2006-10-27 |
2012-03-21 |
Aretais Inc |
Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
EP2126117A2
(en)
*
|
2007-01-18 |
2009-12-02 |
University Of Southern California |
Gene polymorphisms predictive for dual tki therapy
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
JP5680304B2
(en)
*
|
2007-02-23 |
2015-03-04 |
アイビス バイオサイエンシズ インコーポレイティッド |
Rapid forensic DNA analysis
|
AU2008222563A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008118809A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Ibis Biosciences, Inc. |
Compositions for use in identification of mixed populations of bioagents
|
US8652780B2
(en)
|
2007-03-26 |
2014-02-18 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US20090006002A1
(en)
*
|
2007-04-13 |
2009-01-01 |
Sequenom, Inc. |
Comparative sequence analysis processes and systems
|
DE102007023015A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Dietmar Fassbach |
Container for transporting hot food, in particular pizza
|
WO2009023358A2
(en)
*
|
2007-05-25 |
2009-02-19 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of hepatitis c virus
|
AU2008260029B2
(en)
|
2007-05-31 |
2015-02-12 |
Yale University |
A genetic lesion associated with cancer
|
WO2008151023A2
(en)
|
2007-06-01 |
2008-12-11 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
US8017403B2
(en)
|
2007-06-14 |
2011-09-13 |
Quest Diagnostics Investments Incorporated |
Mass spectrometry method for measuring vitamin B6 in body fluid
|
US20110045456A1
(en)
*
|
2007-06-14 |
2011-02-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious contaminant viruses
|
NZ556506A
(en)
*
|
2007-07-13 |
2010-03-26 |
Ovita Ltd |
Ovine identification method
|
WO2009032781A2
(en)
|
2007-08-29 |
2009-03-12 |
Sequenom, Inc. |
Methods and compositions for universal size-specific polymerase chain reaction
|
US20090180931A1
(en)
|
2007-09-17 |
2009-07-16 |
Sequenom, Inc. |
Integrated robotic sample transfer device
|
US20090134325A1
(en)
|
2007-11-27 |
2009-05-28 |
Goldman Mildred M |
Methods for detecting estradiol by mass spectrometry
|
US7972868B2
(en)
|
2007-11-28 |
2011-07-05 |
Quest Diagnostics Investments Incorporated |
Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
|
US8030084B2
(en)
|
2007-12-06 |
2011-10-04 |
Quest Diagnostics Investments Incorporated |
Thyroglobulin quantitation by mass spectrometry
|
US8916385B2
(en)
|
2007-12-13 |
2014-12-23 |
Quest Diagnostics Investments, Inc. |
Methods for detecting estrone by mass spectrometry
|
EP3699291A1
(en)
|
2008-01-17 |
2020-08-26 |
Sequenom, Inc. |
Single molecule nucleic acid sequence analysis processes and compositions
|
TW200933195A
(en)
*
|
2008-01-28 |
2009-08-01 |
Ind Tech Res Inst |
Autostereoscopic display
|
US20110097704A1
(en)
*
|
2008-01-29 |
2011-04-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of picornaviruses
|
ES2936256T3
(en)
|
2008-02-01 |
2023-03-15 |
Massachusetts Gen Hospital |
Use of microvesicles in the diagnosis, and prognosis of diseases and medical conditions
|
AU2009223671B2
(en)
|
2008-03-11 |
2014-11-27 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
AU2009224113B2
(en)
|
2008-03-12 |
2013-02-21 |
Otago Innovation Limited |
Biomarkers
|
AU2009224114B2
(en)
|
2008-03-12 |
2013-02-21 |
Otago Innovation Limited |
Biomarkers
|
CA2718137A1
(en)
|
2008-03-26 |
2009-10-01 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US20090270601A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Steven Albert Benner |
Differential detection of single nucleotide polymorphisms
|
WO2009151982A1
(en)
*
|
2008-05-30 |
2009-12-17 |
Ibis Biosciences, Inc. |
Compositions for use in identification of francisella
|
WO2009155103A2
(en)
*
|
2008-05-30 |
2009-12-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of tick-borne pathogens
|
WO2009148995A2
(en)
*
|
2008-06-02 |
2009-12-10 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
WO2010012002A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Saryna Medical Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
EP2149612A1
(en)
|
2008-07-29 |
2010-02-03 |
Merck Serono SA |
Genetic markers of response to efalizumab
|
US8106351B2
(en)
*
|
2008-08-08 |
2012-01-31 |
Quest Diagnostics Investments Incorporated |
Mass spectrometry assay for plasma-renin
|
US7834313B2
(en)
*
|
2008-08-08 |
2010-11-16 |
Quest Diagnostics Investments Incorporated |
Mass spectrometry assay for plasma-renin
|
US7893399B2
(en)
*
|
2008-09-09 |
2011-02-22 |
Quest Diagnostics Investments Incorporated |
Methods for detecting dehydroepiandrosterone by mass spectrometry
|
US9121844B1
(en)
*
|
2008-09-09 |
2015-09-01 |
Sociedad Europea de Analisis Diferencial de Movilidad |
Method to analyze and classify persons and organisms based on odor patterns from released vapors
|
EP2347254A2
(en)
|
2008-09-16 |
2011-07-27 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
EP2349549B1
(en)
|
2008-09-16 |
2012-07-18 |
Ibis Biosciences, Inc. |
Mixing cartridges, mixing stations, and related kits, and system
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
EP2344893B1
(en)
|
2008-09-16 |
2014-10-15 |
Ibis Biosciences, Inc. |
Microplate handling systems and methods
|
JP5727375B2
(en)
|
2008-09-16 |
2015-06-03 |
セクエノム, インコーポレイテッド |
Process and composition for methylation-based enrichment of fetal nucleic acid from maternal samples useful for non-invasive prenatal diagnosis
|
US8476013B2
(en)
*
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2010039755A1
(en)
*
|
2008-10-02 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial genus mycoplasma
|
US20110200985A1
(en)
*
|
2008-10-02 |
2011-08-18 |
Rangarajan Sampath |
Compositions for use in identification of herpesviruses
|
US20110183344A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Rangarajan Sampath |
Compositions for use in identification of clostridium difficile
|
WO2010039775A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial class alphaproteobacter
|
WO2010039870A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of neisseria, chlamydia, and/or chlamydophila bacteria
|
WO2010039848A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of streptococcus pneumoniae
|
WO2010039763A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of antibiotic-resistant bacteria
|
US7804063B2
(en)
*
|
2008-10-06 |
2010-09-28 |
Quest Diagnostics Investments Incorporated |
Methods for detecting dihydrotestosterone by mass spectrometry
|
US7952067B2
(en)
|
2008-10-06 |
2011-05-31 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin C by mass spectrometry
|
EP2347015A4
(en)
*
|
2008-10-29 |
2012-12-19 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
WO2010077832A1
(en)
|
2008-12-15 |
2010-07-08 |
Wisconsin Alumni Research Foundation |
Methods and compositions for testing and breeding cattle for improved fertility and embryonic survival
|
US8039794B2
(en)
|
2008-12-16 |
2011-10-18 |
Quest Diagnostics Investments Incorporated |
Mass spectrometry assay for thiopurine-S-methyl transferase activity and products generated thereby
|
US7952068B2
(en)
|
2008-12-16 |
2011-05-31 |
Quest Diagnostics Investments Incorporated |
Methods for detecting catecholamines by mass spectrometry
|
US8399829B2
(en)
*
|
2008-12-18 |
2013-03-19 |
Quest Diagnostics Investments Incorporated |
Vitamin B2 detection by mass spectrometry
|
EP2358905A1
(en)
*
|
2008-12-19 |
2011-08-24 |
Abbott Laboratories |
Diagnostic test for mutations in codons 12-13 of human k-ras
|
WO2010080616A1
(en)
|
2008-12-19 |
2010-07-15 |
Abbott Laboratories |
Molecular assay for diagnosis of malaria
|
US20100155594A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Goldman Mildred M |
Mass spectrometry assay for estrogenic compounds
|
US8153962B2
(en)
|
2008-12-24 |
2012-04-10 |
Quest Diagnostics Investments Incorporated |
Mass spectrometry assay for congenital adrenal hyperplasia
|
US8110796B2
(en)
|
2009-01-17 |
2012-02-07 |
The George Washington University |
Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
|
CA2751287A1
(en)
|
2009-02-06 |
2010-09-10 |
Yale University |
A snp marker of breast and ovarian cancer risk
|
EP2394175B1
(en)
*
|
2009-02-09 |
2016-02-03 |
caprotec bioanalytics GmbH |
Devices, systems and methods for separating magnetic particles
|
JP2012517238A
(en)
|
2009-02-11 |
2012-08-02 |
カリス エムピーアイ インコーポレイテッド |
Molecular profiling of tumors
|
US8158936B2
(en)
|
2009-02-12 |
2012-04-17 |
Ibis Biosciences, Inc. |
Ionization probe assemblies
|
WO2010104798A1
(en)
|
2009-03-08 |
2010-09-16 |
Ibis Biosciences, Inc. |
Bioagent detection methods
|
EP2408936A4
(en)
*
|
2009-03-18 |
2013-01-30 |
Sequenom Inc |
Use of thermostable endonucleases for generating reporter molecules
|
US9393564B2
(en)
|
2009-03-30 |
2016-07-19 |
Ibis Biosciences, Inc. |
Bioagent detection systems, devices, and methods
|
EP3211095B1
(en)
|
2009-04-03 |
2019-01-02 |
Sequenom, Inc. |
Nucleic acid preparation compositions and methods
|
US9490113B2
(en)
*
|
2009-04-07 |
2016-11-08 |
The George Washington University |
Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
|
WO2010124257A2
(en)
*
|
2009-04-24 |
2010-10-28 |
Colby Pharmaceutical Company |
Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
EP2446056A2
(en)
|
2009-06-25 |
2012-05-02 |
Yale University |
Single nucleotide polymorphisms in brca1 and cancer risk
|
BR112012001077A2
(en)
|
2009-07-16 |
2020-08-11 |
The General Hospital Corporation |
nucleic acid extraction, methods to assess the quality of a nucleic acid extraction and biological sample, to obtain nucleic acid from a biological sample, to analyze microvesicle rna and to diagnose and monitor an individual, and, kit
|
WO2011008971A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
WO2011008972A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Systems for bioagent identification
|
WO2011014811A1
(en)
|
2009-07-31 |
2011-02-03 |
Ibis Biosciences, Inc. |
Capture primers and capture sequence linked solid supports for molecular diagnostic tests
|
WO2011013019A1
(en)
|
2009-07-31 |
2011-02-03 |
Centre Hospitalier Universitaire Vaudois |
Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients
|
DE102009035587B3
(en)
*
|
2009-07-31 |
2011-03-24 |
Siemens Aktiengesellschaft |
Method for filtering a chromatogram
|
EP3098325A1
(en)
|
2009-08-06 |
2016-11-30 |
Ibis Biosciences, Inc. |
Non-mass determined base compositions for nucleic acid detection
|
US20110065111A1
(en)
*
|
2009-08-31 |
2011-03-17 |
Ibis Biosciences, Inc. |
Compositions For Use In Genotyping Of Klebsiella Pneumoniae
|
EP3461912B1
(en)
|
2009-09-09 |
2022-07-13 |
The General Hospital Corporation |
Use of microvesicles in analyzing nucleic acid profiles
|
EP2475989A4
(en)
|
2009-09-09 |
2013-02-27 |
Gen Hospital Corp |
Use of microvesicles in analyzing kras mutations
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
WO2011041695A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Ibis Biosciences, Inc. |
Determination of methylation status of polynucleotides
|
US9890408B2
(en)
*
|
2009-10-15 |
2018-02-13 |
Ibis Biosciences, Inc. |
Multiple displacement amplification
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
CN102596230B
(en)
|
2009-11-05 |
2015-08-05 |
奎斯特诊断投资公司 |
Insulin like growth factor-1 and Insulin-like growth factor-II is quantized by high resolution mass spec method
|
CA2780875A1
(en)
|
2009-11-13 |
2011-05-19 |
Pangaea Biotech, S.L. |
Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
|
WO2011067712A1
(en)
|
2009-12-03 |
2011-06-09 |
Basf Plant Science Company Gmbh |
Expression cassettes for embryo-specific expression in plants
|
US7977117B2
(en)
|
2009-12-03 |
2011-07-12 |
Quest Diagnostics Investments Incorprated |
Vitamin D metabolite determination utilizing mass spectrometry following derivatization
|
US8034627B2
(en)
|
2009-12-03 |
2011-10-11 |
Quest Diagnostics Investments Incorporated |
Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
|
US20110240840A1
(en)
|
2009-12-11 |
2011-10-06 |
Quest Diagnostics Investments Incorporated |
Mass spectrometric determination of cookson-derivatized, non-metabolized vitamin d
|
CN107607662B
(en)
|
2009-12-11 |
2020-05-08 |
奎斯特诊断投资公司 |
Mass spectrometry of steroids in multiplex samples
|
WO2011084751A1
(en)
|
2009-12-21 |
2011-07-14 |
Quest Diagnostics Investments Incorporated |
Glucagon detection and quantitation by mass spectrometry
|
WO2011084757A1
(en)
|
2009-12-21 |
2011-07-14 |
University Of Southern California |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
ES2577017T3
(en)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedures and kits to identify aneuploidy
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
ES2587191T3
(en)
|
2009-12-23 |
2016-10-21 |
Arca Biopharma, Inc. |
Methods and compositions for cardiovascular diseases and conditions
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
TWI518325B
(en)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
Identification, assessment, and therapy of cancers with innate or acquired resistance to alk inhibitors
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US9758840B2
(en)
*
|
2010-03-14 |
2017-09-12 |
Ibis Biosciences, Inc. |
Parasite detection via endosymbiont detection
|
WO2011156505A1
(en)
|
2010-06-09 |
2011-12-15 |
Quest Diagnostics Investments Incorporated |
Mass spectrometric determination of derivatized methylmalonic acid
|
ES2629850T3
(en)
|
2010-07-19 |
2017-08-16 |
Otago Innovation Limited |
Signal biomarkers
|
WO2012031008A2
(en)
|
2010-08-31 |
2012-03-08 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
JP5894078B2
(en)
*
|
2010-10-29 |
2016-03-23 |
アトナープ株式会社 |
Sampling device
|
CA2816991C
(en)
|
2010-11-05 |
2020-06-09 |
Morphotek Inc. |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
US9012835B2
(en)
|
2010-11-08 |
2015-04-21 |
Georgetown University |
Methods for simultaneous quantification of thyroid hormones and metabolites thereof by mass spectrometry
|
CA2817111C
(en)
|
2010-11-10 |
2019-03-05 |
Exosome Diagnostics, Inc. |
Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
EP2638163B1
(en)
|
2010-11-12 |
2017-05-17 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
WO2012088222A2
(en)
|
2010-12-21 |
2012-06-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
CA2823324C
(en)
|
2010-12-28 |
2019-12-31 |
Quest Diagnostics Investments Incorporated |
Quantitation of insulin by mass spectrometry
|
US9177766B2
(en)
|
2010-12-30 |
2015-11-03 |
Quest Diagnostics Investments Incorporated |
Mass spectrometric quantitation assay for metabolites of leflunomide
|
US20140024590A1
(en)
|
2011-02-18 |
2014-01-23 |
Yale University |
KRAS-Variant And Endometriosis
|
EP2492688A1
(en)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molecular biomarkers for predicting response to antitumor treatment in lung cancer
|
SG10201601224WA
(en)
|
2011-03-02 |
2016-03-30 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
US20140065615A1
(en)
|
2011-03-21 |
2014-03-06 |
Yale University |
The KRAS Variant and Tumor Biology
|
AU2012249531B2
(en)
|
2011-04-29 |
2017-06-29 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
AU2012253366A1
(en)
|
2011-05-11 |
2014-01-09 |
Exosome Diagnostics, Inc. |
Nucleic acid extraction from heterogeneous biological materials
|
WO2012159089A1
(en)
|
2011-05-19 |
2012-11-22 |
Sequenom, Inc. |
Products and processes for multiplex nucleic acid identification
|
US8728824B2
(en)
|
2011-06-22 |
2014-05-20 |
Quest Diagnostics Investments Inc. |
Mass spectrometric determination of fatty acids
|
US20140154209A1
(en)
|
2011-06-30 |
2014-06-05 |
Centre Hospitalier Universitaire Vaudois |
Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance
|
EP2748335B1
(en)
|
2011-08-22 |
2018-10-03 |
Exosome Diagnostics, Inc. |
Urine biomarkers
|
ES2704126T3
(en)
|
2011-08-23 |
2019-03-14 |
Found Medicine Inc |
KIF5B-RET fusion molecules and their uses
|
WO2013030786A1
(en)
|
2011-08-31 |
2013-03-07 |
Centre Hospitalier Universitaire Vaudois |
Method for diagnosing or predicting hepatocellular carcinoma outcome
|
WO2013034579A1
(en)
|
2011-09-05 |
2013-03-14 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Biosynthetic gene cluster for the production of peptide/protein analogues
|
WO2013045505A1
(en)
|
2011-09-28 |
2013-04-04 |
Novartis Ag |
Biomarkers for raas combination therapy
|
US20140271542A1
(en)
|
2011-10-05 |
2014-09-18 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Service |
Genetic marker for predicting prognosis in patients infected with hepatitis c virus
|
EP2776587A4
(en)
|
2011-11-10 |
2015-07-15 |
Exosome Diagnostics Inc |
Cerebrospinal fluid assay
|
US9447458B2
(en)
|
2011-11-16 |
2016-09-20 |
Canon U.S. Life Sciences, Inc. |
Detection of neighboring variants
|
US20140305230A1
(en)
*
|
2011-11-22 |
2014-10-16 |
Purdue Research Foundation |
Sample deposition chamber for laser-induced acoustic desorption (liad) foils
|
JP6444736B2
(en)
|
2011-11-23 |
2018-12-26 |
クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド |
Detection of kisspeptin-54 by tandem mass spectrometry
|
CA2857597A1
(en)
|
2011-11-30 |
2013-06-06 |
AbbVie Deutschland GmbH & Co. KG |
Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
|
US8669519B2
(en)
|
2011-12-05 |
2014-03-11 |
Quest Diagnostics Investments, Inc. |
Methods for detecting reverse triiodothyronine by mass spectrometry
|
US8779355B2
(en)
|
2011-12-28 |
2014-07-15 |
Quest Diagnostics Investments, Inc. |
Methods for detecting lacosamide by mass spectrometry
|
US9222115B2
(en)
|
2011-12-30 |
2015-12-29 |
Abbott Molecular, Inc. |
Channels with cross-sectional thermal gradients
|
EP3418397B1
(en)
|
2012-01-24 |
2020-10-07 |
CD Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
EP2820129A1
(en)
|
2012-03-02 |
2015-01-07 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2013131068A1
(en)
|
2012-03-02 |
2013-09-06 |
Berg Pharma, Llc |
Methods and kits for detection of coenzyme q10
|
IN2014DN08537A
(en)
|
2012-03-20 |
2015-05-15 |
Otago Innovation Ltd |
|
EA028984B1
(en)
|
2012-03-29 |
2018-01-31 |
Новартис Аг |
Use of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)pyridin-4-yl]thiazol-2-yl}amide) for treating cancer
|
SG11201406201YA
(en)
|
2012-04-02 |
2014-10-30 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
EP2836482B1
(en)
|
2012-04-10 |
2019-12-25 |
The Regents of The University of California |
Compositions and methods for treating cancer
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
EP2680005A1
(en)
|
2012-06-28 |
2014-01-01 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Lipid analysis
|
US20140004105A1
(en)
|
2012-06-29 |
2014-01-02 |
Sequenom, Inc. |
Age-related macular degeneration diagnostics
|
CN104603290B
(en)
|
2012-06-29 |
2019-02-01 |
Htg分子诊断有限公司 |
For detecting the nuclease protection assays of nucleotide diversity
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2014015098A1
(en)
|
2012-07-18 |
2014-01-23 |
Siemens Healthcare Diagnostics Inc. |
A method of normalizing biological samples
|
CA2880764C
(en)
|
2012-08-03 |
2022-08-30 |
Foundation Medicine, Inc. |
Human papilloma virus as predictor of cancer prognosis
|
US10221456B2
(en)
|
2012-08-06 |
2019-03-05 |
Merck Patent Gmbh |
Genetic markers for predicting responsiveness to FPG-18 compound
|
US9638687B2
(en)
|
2012-08-28 |
2017-05-02 |
Bloodworks |
Biochemical markers of red blood cell storage and toxicity
|
CN104995311A
(en)
|
2012-08-30 |
2015-10-21 |
外来体诊断公司 |
Controls for nucleic acid assays
|
BR112015005887B1
(en)
|
2012-09-20 |
2022-04-19 |
Quest Diagnostics Investments Incorporated |
Method for determining the amount of thyroglobulin in a test sample
|
US20150252428A1
(en)
|
2012-10-03 |
2015-09-10 |
Exosome Diagnostics, Inc. |
Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
|
WO2014055790A2
(en)
|
2012-10-04 |
2014-04-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP2912194B1
(en)
|
2012-10-26 |
2019-05-08 |
Memorial Sloan-Kettering Cancer Center |
Androgen receptor variants and methods for making and using
|
EP2914621B1
(en)
|
2012-11-05 |
2023-06-07 |
Foundation Medicine, Inc. |
Novel ntrk1 fusion molecules and uses thereof
|
CN105102977A
(en)
|
2012-12-26 |
2015-11-25 |
奎斯特诊断投资公司 |
C peptide detection by mass spectrometry
|
CA2898326C
(en)
|
2013-01-18 |
2022-05-17 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
ITUD20130021A1
(en)
|
2013-02-20 |
2014-08-21 |
Alifax Holding S P A |
PROCEDURE FOR THE IDENTIFICATION OF BACTERIAL CLASSES THROUGH GAS CHROMATOGRAPHY / MASS SPECTROMETRY IN BIOLOGICAL SAMPLES
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
JP6440692B2
(en)
|
2013-05-23 |
2018-12-19 |
アイフィノタイプ エルエルシー |
Method and system for assisting individuals, product providers and / or service providers
|
EP2805769A1
(en)
|
2013-05-24 |
2014-11-26 |
European Molecular Biology Laboratory |
Methods for nano-scale single cell analysis
|
EP3008211A4
(en)
|
2013-06-11 |
2016-12-21 |
Courtagen Life Sciences Inc |
Methods and kits for treating and classifying individuals at risk of or suffering from trap1 change-of-function
|
WO2015009831A2
(en)
|
2013-07-17 |
2015-01-22 |
Foundation Medicine, Inc. |
Methods of treating urothelial carcinomas
|
EP3495509B1
(en)
|
2013-08-06 |
2021-12-15 |
Exosome Diagnostics, Inc. |
Urine biomarker cohorts, gene expression signatures, and methods of use thereof
|
JO3805B1
(en)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
Inhibitors of kras g12c
|
EP3117011B1
(en)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP4220178A3
(en)
|
2014-05-12 |
2023-08-16 |
Quest Diagnostics Investments Incorporated |
Quantitation of tamoxifen and metabolites thereof by mass spectrometry
|
CN107209188A
(en)
|
2014-06-27 |
2017-09-26 |
雅培制药有限公司 |
Composition and method for detecting people Pegivirus 2 (HPgV 2)
|
JO3556B1
(en)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
Combination therapies for treatment of cancer
|
EP3197870B1
(en)
|
2014-09-25 |
2020-08-19 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
US10011600B2
(en)
|
2014-09-25 |
2018-07-03 |
Araxes Pharma Llc |
Methods and compositions for inhibition of Ras
|
CA2966044A1
(en)
|
2014-10-30 |
2016-05-06 |
The General Hospital Corporation |
Methods for modulating atrx-dependent gene repression
|
WO2016115496A1
(en)
|
2015-01-15 |
2016-07-21 |
Joslin Diabetes Center |
Metabolite biomarkers predictive of renal disease in diabetic patients
|
US11391742B2
(en)
|
2015-02-10 |
2022-07-19 |
B.R.A.H.M.S. Gmbh |
Free histone proteins as biomarkers
|
US10324082B2
(en)
|
2015-03-03 |
2019-06-18 |
Quest Diagnostics Investments Llc |
Methods for quantitation of insulin levels by mass spectrometry
|
US10900036B2
(en)
|
2015-03-17 |
2021-01-26 |
The General Hospital Corporation |
RNA interactome of polycomb repressive complex 1 (PRC1)
|
EA201792214A1
(en)
|
2015-04-10 |
2018-01-31 |
Араксис Фарма Ллк |
COMPOUNDS OF SUBSTITUTE QUINAZOLINE
|
ES2856880T3
(en)
|
2015-04-15 |
2021-09-28 |
Araxes Pharma Llc |
KRAS Condensed Tricyclic Inhibitors and Methods of Using Them
|
AU2016250849A1
(en)
|
2015-04-24 |
2017-11-02 |
Agena Bioscience, Inc. |
Multiplex methods for detection and quantification of minor variants
|
US10233489B2
(en)
|
2015-04-24 |
2019-03-19 |
Agena Bioscience, Inc. |
Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
KR20180033235A
(en)
|
2015-07-23 |
2018-04-02 |
머크 샤프 앤드 돔 코포레이션 |
Genetic markers associated with response to CRTH2 receptor antagonists
|
CN108136051A
(en)
|
2015-08-04 |
2018-06-08 |
Cd诊断股份有限公司 |
The method for detecting bad local organization reaction (ALTR) necrosis
|
PT3277842T
(en)
|
2015-08-17 |
2019-09-05 |
Kura Oncology Inc |
Methods of treating cancer patients with farnesyl transferase inhibitors
|
EP3356351A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US11360098B2
(en)
|
2015-09-28 |
2022-06-14 |
Quest Diagnostics Investments Llc |
Amyloid beta detection by mass spectrometry
|
US10882847B2
(en)
|
2015-09-28 |
2021-01-05 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
EP3356354A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
WO2017058728A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017070256A2
(en)
|
2015-10-19 |
2017-04-27 |
Araxes Pharma Llc |
Method for screening inhibitors of ras
|
AU2016355433C1
(en)
|
2015-11-16 |
2021-12-16 |
Araxes Pharma Llc |
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
|
WO2017100546A1
(en)
|
2015-12-09 |
2017-06-15 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
WO2017125406A1
(en)
|
2016-01-19 |
2017-07-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting left ventricular remodeling in subjects suffering from hypertension
|
WO2017147186A1
(en)
|
2016-02-22 |
2017-08-31 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
WO2017151517A1
(en)
|
2016-02-29 |
2017-09-08 |
Foundation Medicine, Inc. |
Methods of treating cancer
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
CN109563547A
(en)
|
2016-04-15 |
2019-04-02 |
外来体诊断公司 |
The detection based on blood plasma of anaplastic lymphoma kinase (ALK) nucleic acid and ALK fusion transcript and its purposes in cancer diagnosis and treatment
|
JP2019515035A
(en)
|
2016-04-27 |
2019-06-06 |
ミラ ディーエックス, インコーポレイテッド |
Immunity-based treatment of KRAS variant cancer patients
|
CN109642229A
(en)
|
2016-05-13 |
2019-04-16 |
外来体诊断公司 |
Extracellular vesica is separated from biofluid and isolates the automatically and manually method of Cell-free DNA
|
BR112018072473A2
(en)
|
2016-05-20 |
2019-02-19 |
Basf Agro Bv |
nucleic acid molecule, expression cassette, plant cell, plant, seed, methods for expressing a nucleic acid, producing a plant, controlling vegetation and cultivating the plant, useful combination for control, process for preparing a combination and using a combination
|
WO2018009547A1
(en)
|
2016-07-05 |
2018-01-11 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Diagnosing col6-related disorders and methods for treating same
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
WO2018045162A1
(en)
|
2016-09-01 |
2018-03-08 |
Biogen Ma Inc. |
Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
|
SG11201901941YA
(en)
|
2016-09-14 |
2019-04-29 |
Modernatx Inc |
High purity rna compositions and methods for preparation thereof
|
EP3519402A1
(en)
|
2016-09-29 |
2019-08-07 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
JP2019534260A
(en)
|
2016-10-07 |
2019-11-28 |
アラクセス ファーマ エルエルシー |
Heterocyclic compounds as inhibitors of RAS and methods of use thereof
|
JP2019535307A
(en)
|
2016-10-21 |
2019-12-12 |
エクソサム ダイアグノスティクス,インコーポレイティド |
Sequencing and analysis of exosome-bound nucleic acids
|
JP7280823B2
(en)
|
2016-11-30 |
2023-05-24 |
エクソサム ダイアグノスティクス,インコーポレイティド |
Methods and compositions for detecting mutations in plasma using exosomal RNA and cell-free DNA from patients with non-small cell lung cancer
|
WO2018111662A1
(en)
|
2016-12-14 |
2018-06-21 |
Merck Sharp & Dohme Corp. |
Human genetic markers associated with response to treatments that target clostridium difficile toxin b
|
RU2019121922A
(en)
|
2016-12-15 |
2021-01-18 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
|
WO2018126278A2
(en)
|
2017-01-02 |
2018-07-05 |
Exosome Diagnostics, Inc. |
Methods to distinguish rna and dna in a combined preparation
|
WO2018132639A1
(en)
|
2017-01-13 |
2018-07-19 |
Foster Charles Stephen |
Methods and kits for the diagnosis and/or prognosis of ocular cicatricial pemphigoid
|
US11279689B2
(en)
|
2017-01-26 |
2022-03-22 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer
|
EP3573964A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
WO2018140514A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
CN110382482A
(en)
|
2017-01-26 |
2019-10-25 |
亚瑞克西斯制药公司 |
Condensed miscellaneous-Heterobicyclic compounds and its application method
|
CN110291037A
(en)
*
|
2017-02-17 |
2019-09-27 |
卫理公会医院 |
For determining the composition and method of the infection level in object
|
JP7337701B2
(en)
|
2017-03-31 |
2023-09-04 |
クエスト ダイアグノスティックス インヴェストメンツ エルエルシー |
Method for quantification of insulin and C-peptide
|
US11639346B2
(en)
|
2017-05-25 |
2023-05-02 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
|
TW201906832A
(en)
|
2017-05-25 |
2019-02-16 |
美商亞瑞克西斯製藥公司 |
Compounds for cancer treatment and methods of use thereof
|
BR112019024674A2
(en)
|
2017-05-25 |
2020-06-16 |
Araxes Pharma Llc |
COVALENT KRAS INHIBITORS
|
EP3652315A4
(en)
|
2017-07-12 |
2021-09-01 |
Exosome Diagnostics, Inc. |
Methods for isolating and enriching populations of biofluid- derived extracellular vesicles, and methods of use thereof
|
CN107219110A
(en)
*
|
2017-07-24 |
2017-09-29 |
中国人民解放军第三军医大学第二附属医院 |
Suitable for the MALDI TOF microculture liquid processing methods detected and rapid identification method
|
US11361953B2
(en)
|
2017-07-31 |
2022-06-14 |
Quest Diagnostics Investments Incoporated |
Apolipoprotein E isotype detection by mass spectrometry
|
US11860141B2
(en)
|
2017-08-14 |
2024-01-02 |
Quest Diagnostics Investments Llc |
Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry
|
CA3080119A1
(en)
*
|
2017-10-27 |
2019-05-02 |
Frontier Diagnostics, Llc |
Mass spectrometry methods for carcinoma assessments
|
GB201802123D0
(en)
|
2018-02-09 |
2018-03-28 |
Metabolomic Diagnostics Ltd |
A method of processomg a biological sample
|
AU2019272961A1
(en)
|
2018-05-25 |
2021-01-21 |
Arca Biopharma Inc. |
Methods and compositions involving bucindolol for the treatment of atrial fibrillation
|
WO2019232460A1
(en)
|
2018-06-01 |
2019-12-05 |
Agena Bioscience, Inc. |
Products and processes for nucleic acid detection and quantification
|
CN108913685B
(en)
*
|
2018-07-27 |
2019-07-09 |
迈凯基因科技有限公司 |
The method for removing primer dimer
|
US20210301342A1
(en)
|
2018-09-07 |
2021-09-30 |
Sequenom, Inc. |
Methods, and systems to detect transplant rejection
|
EP3850370A1
(en)
|
2018-09-14 |
2021-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of amniotic fluid peptides for predicting postnatal renal function in congenital anomalies of the kidney and the urinary tract
|
WO2020106853A1
(en)
|
2018-11-20 |
2020-05-28 |
Exosome Diagnostics, Inc. |
Compositions and methods for internal controls of microvesicle isolations
|
WO2020104458A1
(en)
|
2018-11-20 |
2020-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for detecting liver dysfunction in a subject
|
MX2021006234A
(en)
|
2018-11-30 |
2021-09-10 |
Caris Mpi Inc |
Next-generation molecular profiling.
|
WO2020172164A1
(en)
|
2019-02-19 |
2020-08-27 |
Sequenom, Inc. |
Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
|
CN110129893A
(en)
*
|
2019-03-25 |
2019-08-16 |
为康(苏州)基因科技有限公司 |
A kind of preparation method and applications of chip
|
CN112176038A
(en)
*
|
2019-07-01 |
2021-01-05 |
申翌生物科技(杭州)有限公司 |
Buffer composition
|
US20210109063A1
(en)
|
2019-10-10 |
2021-04-15 |
Regeneron Pharmaceuticals, Inc. |
Liquid chromatography- mass spectrometry (lc-ms) methods for analyzing ampholyte lot variation
|
IL293489A
(en)
|
2019-12-02 |
2022-08-01 |
Caris Mpi Inc |
Pan-cancer platinum response predictor
|
CA3165815A1
(en)
|
2020-01-31 |
2021-08-05 |
Ming Huang |
Use of liquid chromatography and mass spectrometry to characterize oligonucleotides
|
US20230120825A1
(en)
|
2020-02-28 |
2023-04-20 |
Laboratory Corporation Of America Holdings |
Compositions, Methods, and Systems for Paternity Determination
|
WO2021204948A1
(en)
|
2020-04-09 |
2021-10-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions to determine the quality of red blood cell units
|
JP2020150946A
(en)
*
|
2020-04-13 |
2020-09-24 |
国立大学法人大阪大学 |
METHOD FOR MEASURING METHYLATION MODIFICATION SITE AT microRNA
|
EP4343004A2
(en)
|
2020-10-19 |
2024-03-27 |
Dana-Farber Cancer Institute, Inc. |
Germline biomarkers of clinical response and benefit to immune checkpoint inhibitor therapy
|
PE20231656A1
(en)
|
2020-11-02 |
2023-10-17 |
Trethera Corp |
CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND THEIR USES
|
KR20230156643A
(en)
|
2021-03-17 |
2023-11-14 |
가부시키가이샤 닛스이 |
Purification methods and purified products
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
WO2023201226A1
(en)
|
2022-04-11 |
2023-10-19 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for universal tumor cell killing
|
WO2024074685A1
(en)
|
2022-10-07 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Use of albumin isoforms profiles for the characterization of the etiology and severity of liver injuries
|